Learn more about cholesterol management in PCOS
Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake
Who Should Take Semaglutide for Weight Loss The FDA approved semaglutide specifically for chronic weight management in certain patients: BMI 30 kg/m^2 (obesity) BMI 27 kg/m^2 plus at least one weight-related health issue like type 2 diabetes or hypertension Those with a history of certain medical conditions should not take semaglutide: Multiple endocrine neoplasia syndrome type 2 (MEN 2) Medullary thyroid carcinoma Severe gastrointestinal disease Always consult a healthcare professional before starting semaglutide
However, on landmark analysis of impact of echocardiographic changes within the first 180 days post-TIPS on subsequent mortality, increasing left atrial volume index (LAVI) was associated with increased mortality (HR 1.08 [1.01-1.15] per unit ml/m 2 )
During exercise, this decreased thirst perception can lead to inadequate hydration